Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Bibby

Showing results (11-20 of 204) with videos related to

Pageof 21
Sort By:
BMJ (Clinical Research Ed.)|March 10, 2007
Academia needs to acknowledge the needs of traineesAnna C Bibby
British Journal of Cancer|April 17, 1999
Making the most of rodent tumour systems in cancer drug discoveryM C Bibby
British Journal of Cancer|January 1, 1991
Flavone acetic acid--an interesting novel therapeutic agent or just another disappointment?M C Bibby
European Journal of Cancer (Oxford, England : 1990)|May 4, 2004
Orthotopic models of cancer for preclinical drug evaluation: advantages and disadvantagesM C Bibby
Methods in Molecular Biology (Clifton, N.J.)|April 16, 2002
Introduction to telomeres and telomeraseMichael C Bibby
Thorax|May 8, 2026
National mesothelioma networks: platforms for better care and research opportunitiesAnna C Bibby
Zeitschrift Fur Parasitenkunde (Berlin, Germany)|January 1, 1971
The uptake of radio-active glucose in vivo and in vitro by the metacercaria of Diplostomum phoxini (Faust) and its conversion to glycogenM C Bibby, G Rees
Zeitschrift Fur Parasitenkunde (Berlin, Germany)|January 1, 1971
The ultrastructure of the epidermis and associated structures in the metacercaria cercaria and sporocyst of Diplostomum phoxini (Faust, 1918)M C Bibby, G Rees
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 15, 2005
50 years of preclinical anticancer drug screening: empirical to target-driven approachesMarie Suggitt, Michael C Bibby
Journal of Cancer Research and Clinical Oncology|January 1, 1986
Activity of N-[N'-(2-chloroethyl)-N'-nitrosocarbamoyl]-alanine and derivatives against transplantable adenocarcinomata of the mouse colon (MAC)M C Bibby, J A Double
Pageof 21

Showing results (11-20 of 204) with videos related to

Sort By:
Pageof 21
BMJ (Clinical Research Ed.)|March 10, 2007
Academia needs to acknowledge the needs of traineesAnna C Bibby
British Journal of Cancer|April 17, 1999
Making the most of rodent tumour systems in cancer drug discoveryM C Bibby
British Journal of Cancer|January 1, 1991
Flavone acetic acid--an interesting novel therapeutic agent or just another disappointment?M C Bibby
European Journal of Cancer (Oxford, England : 1990)|May 4, 2004
Orthotopic models of cancer for preclinical drug evaluation: advantages and disadvantagesM C Bibby
Methods in Molecular Biology (Clifton, N.J.)|April 16, 2002
Introduction to telomeres and telomeraseMichael C Bibby
Thorax|May 8, 2026
National mesothelioma networks: platforms for better care and research opportunitiesAnna C Bibby
Zeitschrift Fur Parasitenkunde (Berlin, Germany)|January 1, 1971
The uptake of radio-active glucose in vivo and in vitro by the metacercaria of Diplostomum phoxini (Faust) and its conversion to glycogenM C Bibby, G Rees
Zeitschrift Fur Parasitenkunde (Berlin, Germany)|January 1, 1971
The ultrastructure of the epidermis and associated structures in the metacercaria cercaria and sporocyst of Diplostomum phoxini (Faust, 1918)M C Bibby, G Rees
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 15, 2005
50 years of preclinical anticancer drug screening: empirical to target-driven approachesMarie Suggitt, Michael C Bibby
Journal of Cancer Research and Clinical Oncology|January 1, 1986
Activity of N-[N'-(2-chloroethyl)-N'-nitrosocarbamoyl]-alanine and derivatives against transplantable adenocarcinomata of the mouse colon (MAC)M C Bibby, J A Double
Pageof 21